Related Content
Search Google Scholar for:
More Information
Related Jobs from ScienceCareers
|
|
Science 27 July 2007: Vol. 317. no. 5837, p. 477 DOI: 10.1126/science.1142658
|
|
Brevia
AAV Vector Integration Sites in Mouse Hepatocellular Carcinoma
Anthony Donsante,1*
Daniel G. Miller,2*
Yi Li,3,4
Carole Vogler,5
Elizabeth M. Brunt,5
David W. Russell,3,4
Mark S. Sands1,6
Adeno-associated viruses (AAV) are promising gene therapy vectors that have little or no acute toxicity. We show that normal mice and mice with mucopolysaccharidosis VII (MPS VII) develop hepatocellular carcinoma (HCC) after neonatal injection of an AAV vector expressing b-glucuronidase. AAV proviruses were isolated from four tumors and were all located within a 6-kilobase region of chromosome 12. This locus encodes several imprinted transcripts, small nucleolar RNAs (snoRNAs), and microRNAs. Transcripts from adjacent genes encoding snoRNAs and microRNAs were overexpressed in tumors. Our findings implicate this locus in the development of HCC and raise concerns over the clinical use of AAV vectors.
1 Department of Internal Medicine, Washington University School of Medicine, Box 8007, 660 South Euclid Avenue, St. Louis, MO 63110, USA.
2 Department of Pediatrics, University of Washington, Seattle, WA 98112, USA.
3 Department of Medicine, University of Washington, Mail Stop 357720, Seattle, WA 98112, USA.
4 Department of Biochemistry, University of Washington, Seattle, WA 98112, USA.
5 Department of Pediatrics, St. Louis University School of Medicine, St. Louis, MO 63104, USA.
6 Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA.
* These authors contributed equally to this study.
To whom correspondence should be addressed. E-mail: msands{at}im.wustl.edu (M.S.S.); drussell{at}u.washington.edu (D.W.R.)
Read the Full Text
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy.
- G. P. Niemeyer, R. W. Herzog, J. Mount, V. R. Arruda, D. M. Tillson, J. Hathcock, F. W. van Ginkel, K. A. High, and C. D. Lothrop Jr (2009)
Blood
113, 797-806
| Abstract »
| Full Text »
| PDF »
- Frequency and Spectrum of Genomic Integration of Recombinant Adeno-Associated Virus Serotype 8 Vector in Neonatal Mouse Liver.
- K. Inagaki, C. Piao, N. M. Kotchey, X. Wu, and H. Nakai (2008)
J. Virol.
82, 9513-9524
| Abstract »
| Full Text »
| PDF »
- Adeno-Associated Virus Vector Genomes Persist as Episomal Chromatin in Primate Muscle.
- M. Penaud-Budloo, C. Le Guiner, A. Nowrouzi, A. Toromanoff, Y. Cherel, P. Chenuaud, M. Schmidt, C. von Kalle, F. Rolling, P. Moullier, et al. (2008)
J. Virol.
82, 7875-7885
| Abstract »
| Full Text »
| PDF »
- Ku70, an essential gene, modulates the frequency of rAAV-mediated gene targeting in human somatic cells.
- F. J. Fattah, N. F. Lichter, K. R. Fattah, S. Oh, and E. A. Hendrickson (2008)
PNAS
105, 8703-8708
| Abstract »
| Full Text »
| PDF »
- Gene Therapy in Heart Failure.
- L. E. Vinge, P. W. Raake, and W. J. Koch (2008)
Circ. Res.
102, 1458-1470
| Abstract »
| Full Text »
| PDF »
- Genetic Enhancement of Stem Cell Engraftment, Survival, and Efficacy.
- M. S. Penn and A. A. Mangi (2008)
Circ. Res.
102, 1471-1482
| Abstract »
| Full Text »
| PDF »
- Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.
- L. Zhang, S. Volinia, T. Bonome, G. A. Calin, J. Greshock, N. Yang, C.-G. Liu, A. Giannakakis, P. Alexiou, K. Hasegawa, et al. (2008)
PNAS
105, 7004-7009
| Abstract »
| Full Text »
| PDF »
- Development of gene therapy for blood disorders.
- A. W. Nienhuis (2008)
Blood
111, 4431-4444
| Abstract »
| Full Text »
| PDF »
- MeCP2-dependent repression of an imprinted miR-184 released by depolarization.
- T. Nomura, M. Kimura, T. Horii, S. Morita, H. Soejima, S. Kudo, and I. Hatada (2008)
Hum. Mol. Genet.
17, 1192-1199
| Abstract »
| Full Text »
| PDF »
- Epstein-Barr Virus Nuclear Antigen 1 Does Not Cause Lymphoma in C57BL/6J Mice.
- M.-S. Kang, V. Soni, R. Bronson, and E. Kieff (2008)
J. Virol.
82, 4180-4183
| Abstract »
| Full Text »
| PDF »
- SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer.
- X.-Y. Dong, C. Rodriguez, P. Guo, X. Sun, J. T. Talbot, W. Zhou, J. Petros, Q. Li, R. L. Vessella, A. S. Kibel, et al. (2008)
Hum. Mol. Genet.
17, 1031-1042
| Abstract »
| Full Text »
| PDF »
- Adeno-associated virus (AAV)-mediated transduction of male germ line stem cells results in transgene transmission after germ cell transplantation.
- A. Honaramooz, S. Megee, W. Zeng, M. M. Destrempes, S. A. Overton, J. Luo, H. Galantino-Homer, M. Modelski, F. Chen, S. Blash, et al. (2008)
FASEB J
22, 374-382
| Abstract »
| Full Text »
| PDF »
|
|